Woods Lori A 4
4 · Perspective Therapeutics, Inc. · Filed Apr 19, 2023
Insider Transaction Report
Form 4
Woods Lori A
Director
Transactions
- Exercise/Conversion
Common Stock
2023-04-13$0.61/sh+163,934$100,000→ 1,310,972 total(indirect: By Trust) - Exercise/Conversion
Stock Options (right to buy)
2023-04-17−23,566→ 0 totalExercise: $0.61Exp: 2030-06-23→ Common Stock (0 underlying) - Exercise/Conversion
Common Stock
2023-04-17$0.61/sh+23,566$14,375→ 1,334,538 total(indirect: By Trust) - Exercise/Conversion
Stock Options (right to buy)
2023-04-13−163,934→ 0 totalExercise: $0.61Exp: 2030-06-23→ Common Stock (23,566 underlying)
Holdings
- 48,076
Common Stock
Footnotes (1)
- [F1]250,000 stock options were granted on 6/23/2020. 25% vested on 6/23/2020, 25% vested on 6/23/2021, 25% vested on 6/23/2022 and the remaining 25% vested on 2/3/2023.